Translation of "behavior assessment the dysexecutive syndrome " (English → French) :

In order to minimise the public health consequences of cross-border threats to health as set out in Decision No 1082/2013/EU of the European Parliament and of the Council (7), which could range from mass contamination caused by chemical incidents to pandemics, like those unleashed recently by E. coli, influenza strain H1N1 or SARS (severe acute respiratory syndrome), or health effects resulting from increasing population movements, the Programme should contribute to the creation and maintenance of robust mechanisms and tools to detect, assess and manage major cr ...[+++]oss-border health threats.

(11) To minimise the public health consequences of cross-border health threats which could range from mass contamination caused by chemical incidents to pandemics, like those unleashed recently by E coli, influenza strain H1N1 or SARS (severe acute respiratory syndrome), the Programme should contribute to the creation and maintenance of robust mechanisms and tools to detect, assess and manage major cross-border health threats..

One is that the first nations child and family service agencies in New Brunswick have worked along with health authorities, health officials, to develop a holistic and comprehensive response for fetal alcohol syndrome, including the revisiting of the tools used to assess fetal alcohol syndrome and respond to it.

In its assessment of the British proposal, AI warns of the danger of the 'Sangatte syndrome' reappearing on a large scale as processing centres will attract smugglers and traffickers and contribute to widespread organised crime.

– (EL) The Extraordinary Council on Employment, Social Policy, Health and Consumer Affairs held on 6 May 2003 approved conclusions in which, having carefully examined the situation regarding Severe Acute Respiratory Syndrome, both inside the European Union and world-wide, and the different measures taken to address it, confirmed the importance of a quick assessment of the situation and review of future action.

Q-91 Mr. Cummins (Delta South Richmond) With reference to the antimalarial drug mefloquine administered to Canadian Forces bound for Somalia in 1992-93 and the legal framework under which it was available for use and administered: (a) was mefloquine a licensed drug when it was administered to Canadian Forces, if not what was its status, and how was it legally available; (b) were the Canadian Forces participating in the Lariam (mefloquine) Safety Monitoring Study during this period; (c) was the mefloquine administered in accordance with the Lariam Safety Monitoring Study and the Food and Drugs Act; (d) who was the " principal investigator" responsible for the Lariam Safety Monitoring Study in the Canadian Forces; (e) who was the Canadia ...[+++]n Forces physician responsible to the " principal investigator" of the Lariam Safety Monitoring Study; (f) what was the role of Canadian Forces physician, Dr. Martin Tepper, in the Lariam Safety Monitoring Study; (g) who was responsible for the Lariam Safety Monitoring Study at the Department of Health's Health Protection Branch during this period; (h) what was the role and responsibility of the Health Protection Branch under the Lariam Safety Monitoring Study and the Food and Drugs Act and its regulations in regard to the use of mefloquine by Canadian Forces personnel; (i) when did the Health Protection Branch become aware that mefloquine was being administered to Canadian Forces personnel bound for Somalia; (j) what responsibility did the Canadian Forces have under the Lariam Safety Monitoring Study and the Food and Drugs Act prior to the licensing of mefloquine to inform the manufacturer of its use; (k) what responsibility did the Canadian Forces have under the Lariam Safety Monitoring Study and the Food and Drugs Act to the soldiers who were administered the drug; (l) did the Canadian Forces fulfil their responsibility to the manufacturer under the Lariam Safety Monitoring Study and the Food and Dru ...